BFRA

Biofrontera News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Biofrontera AG BFRA NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.18 -2.62% 6.69 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.81 6.62 6.895 6.69 6.87
more quote information »

Recent News

Date Time Source Heading
6/07/202110:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/07/202110:00GLOBEBiofrontera reports preliminary revenue for the month of May..
5/11/202111:43SEEKBiofrontera reports Q1 results
5/11/202110:41GLOBEBiofrontera reports Q1 2021 financial results
5/06/202116:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/06/202107:52SEEKBiofrontera trades in green on higher prelim revenue for..
5/06/202107:23GLOBEBiofrontera reports preliminary revenue for the month of..
5/03/202111:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/03/202109:40GLOBEBiofrontera AG: First quarter conference call to be held on..
4/12/202117:31EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
4/12/202117:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/12/202114:05SEEKBiofrontera reports Q4 results
4/12/202113:57GLOBEBiofrontera reports results for the 2020 financial year
4/08/202114:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/08/202113:49SEEKBiofrontera provides preliminary revenue for 1Q21
4/08/202110:30GLOBEBiofrontera announces preliminary revenue for Q1 2021
3/31/202113:54EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/31/202110:12GLOBEBiofrontera announces conference call to be held on April..
3/31/202106:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/31/202103:40GLOBEBiofrontera submits application for FDA approval of new..
3/30/202107:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/29/202111:00SEEKHumanigen, Universe Pharmaceuticals leads healthcare..
3/16/202106:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/04/202106:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/03/202114:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/03/202114:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/01/202113:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/26/202117:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/26/202110:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/26/202109:20GLOBEBiofrontera AG announces the closing of the capital raise..
2/25/202116:28EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/25/202116:06EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
2/25/202115:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/25/202111:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/25/202106:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/25/202106:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/24/202111:31SEEKBiofrontera prices $8.9M public offering of ADS; shares down..
2/24/202110:59SEEKSunesis Pharmaceuticals, Owens & Minor leads healthcare..
2/24/202110:38EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/24/202108:30GLOBEBiofrontera submits study report of pharmacokinetics study..
2/24/202106:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/23/202119:54GLOBEBiofrontera AG Announces Pricing of US$8.9 Million Firm..
2/18/202115:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/18/202115:14EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/18/202110:20EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/11/202116:45EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/08/202110:33EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
2/08/202108:57EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/08/202108:45EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/08/202106:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
See more news about this stock »


Your Recent History
NASDAQ
BFRA
Biofronter..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.